BioNTech has signed two new deals with manufacturers to produce lipids at scale, while Moderna's supplier told Reuters it has recently doubled its monthly production of the key ingredients.
Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback